“…Based on the current vulvodynia literature, inflammation is believed to play a key role in the disease mechanism and is present throughout the disease course; exogenous stimuli such as conserved pathogen-associated molecular patterns (PAMPs) or endogenous stimuli such as interleukin-1b (IL-1b) can stimulate this response. 1,8,13,[30][31][32][33][34]39,40,58,59,78,97,101,115 Therefore, we evaluated the effect of 4aPDD on cells either pretreated or concurrently treated with the inflammatory stimulator IL-1b. In cells pretreated overnight with IL-1b, calcium signaling activity was apparent with all doses of 4aPDD, with or without an additional IL-1b treatment (Fig.…”